TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT06233942 — Predictive Biomarker (PRD): VTCN1 mRNA
Genes: VTCN1; B7H4; UNQ659/PRO1291
Study NCT05610280 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT06607900 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06420518 — Predictive Biomarker (PRD): CKM mRNA
Genes: CKM; CKMM
Study NCT04763083 — Predictive Biomarker (PRD): RORA
Genes: RZRA; ROR1; ROR2; ROR3; NR1F1; ROR-alpha; RORalpha; RORa1
Study NCT06770972 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06106672 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study NCT05911399 — Predictive Biomarker (PRD): SLC16A2 mRNA
Genes: SLC16A2; MCT7; MCT8; XPCT
Study NCT06191900 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT04255758 — Predictive Biomarker (PRD): MREG mRNA
Genes: MREG; DSU; HDCGA21P
Study NCT04898738 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04827979 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05103605 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04638439 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06639607 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT06276140 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04462406 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03554707 — Predictive Biomarker (PRD): SGTA mRNA
Genes: SGTA; SGT; SGT1
Study NCT05274347 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04974879 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04974879 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04875416 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04875416 — Predictive Biomarker (PRD): TMPRSS13 mRNA
Genes: TMPRSS13; MSP; TMPRSS11
Study NCT06131346 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06174857 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05013112 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT05013112 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06419712 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05266495 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05037006 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT06105021 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06105021 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT04818632 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04818632 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04640571 — Predictive Biomarker (PRD): SLC10A2 mRNA
Genes: SLC10A2; ASBT; ISBT; NTCP2
Study NCT04864821 — Predictive Biomarker (PRD): CD276 mRNA
Genes: CD276; B7H3; PSEC0249; UNQ309/PRO352
Study NCT04981509 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05908175 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT06645041 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06238622 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05809934 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study NCT05747625 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05459688 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06186882 — Predictive Biomarker (PRD): DCDC2 mRNA
Genes: DCDC2; KIAA1154; RU2
Study NCT04876053 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06072807 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT06072807 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05597995 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT03927066 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04839172 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05644561 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT05567874 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04915612 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT06036641 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06036641 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06036641 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT06064708 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06064708 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06064708 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06165562 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06419361 — Predictive Biomarker (PRD): STING1 mRNA
Genes: STING1; ERIS; MITA; STING; TMEM173
Study NCT06237309 — Predictive Biomarker (PRD): NPR1 mRNA
Genes: NPR1; ANPRA
Study NCT05536531 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05536531 — Safety Biomarker (SAF): BDNF
Study NCT06442761 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06442761 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00416871 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04874545 — Predictive Biomarker (PRD): ABR mRNA
Genes: ABR
Study NCT05234177 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06166017 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT06491862 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT06739226 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06739226 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study NCT06740955 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT06738966 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06738966 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06738966 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06738966 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05879068 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05142189 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT04753203 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT05910632 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06150677 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05614960 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05429372 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05232149 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05594355 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04231838 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05934071 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05934071 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT04763005 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06625333 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06625333 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05662163 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Heart fatty acid-binding protein
Genes: FABP3; FABP11; MDGI
Study NCT05781386 — Predictive Biomarker (PRD): TNFRSF1B mRNA
Genes: TNFRSF1B; TNFBR; TNFR2
Study NCT05781386 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05040256 — Predictive Biomarker (PRD): LRBA mRNA
Genes: LRBA; BGL; CDC4L; LBA
Study NCT05040256 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT06310590 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT00000694 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00000694 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06626919 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06632613 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05729217 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06550882 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT06773143 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06773143 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06195618 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT06284070 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06772233 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT06772480 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06772480 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06773806 — Predictive Biomarker (PRD): DDT mRNA
Genes: DDT
Study NCT06641089 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04953650 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05882266 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05389319 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05944185 — Predictive Biomarker (PRD): MSLN mRNA
Genes: MSLN; MPF
Study NCT06775145 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT06773377 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study NCT06774443 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT06121700 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06775132 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06313983 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05500027 — Predictive Biomarker (PRD): CD58 mRNA
Genes: CD58; LFA3
Study NCT05345093 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06773988 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06376084 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06376084 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05565092 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06772623 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06772623 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06463457 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05843448 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT06484062 — Safety Biomarker (SAF): CDA
Genes: CDD
Study NCT05952557 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05952557 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06331663 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04105920 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06111768 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05601440 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05601440 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05826535 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03341897 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT05176080 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05176080 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05176080 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05203510 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT06130371 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06130371 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05526950 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT05034055 — Predictive Biomarker (PRD): STING1 mRNA
Genes: STING1; ERIS; MITA; STING; TMEM173
Study NCT05656105 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT06475898 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT05701215 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT05948657 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04671914 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04504136 — Predictive Biomarker (PRD): ACAD8 mRNA
Genes: ACAD8; ARC42; IBD
Study NCT04504136 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study NCT04504136 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT06191133 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT06191133 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT06128811 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05353790 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05748600 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06712719 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT06712719 — Surrogate Endpoint (SUR): Serum phosphate
Study NCT06712719 — Surrogate Endpoint (SUR): Serum calcium
Study NCT04814186 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT06449235 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT06455761 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05362812 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06090331 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT04961372 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06213688 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT05942404 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study NCT05942404 — Safety Biomarker (SAF): BDNF
Study NCT06572930 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT04892511 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04362891 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06023199 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05875740 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study NCT06397768 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06492447 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05471193 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06497660 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05188365 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05269511 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05992909 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT06588478 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06284538 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05347498 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT05594680 — Predictive Biomarker (PRD): CAMP mRNA
Genes: CAMP; CAP18; FALL39; HSD26
Study NCT05594680 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT05594680 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study NCT00002087 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00002087 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT04660929 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06257264 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06257264 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06257264 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06257264 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06257264 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05704322 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05704322 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05446870 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04793464 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05353738 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT05353738 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05343663 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05991050 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05419830 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06500273 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06500273 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study NCT04827836 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06499194 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06434194 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06772610 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06739993 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05340335 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06062823 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03660722 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06770764 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06346379 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06531499 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06779942 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06781294 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06252285 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06781996 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05672082 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT05978648 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05978648 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05978648 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04847479 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06402604 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04871308 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT04862663 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04862663 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04862663 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05800756 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05800756 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04813718 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04813718 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT04813718 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT04813718 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT04813718 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT04704661 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05493293 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT05266196 — Predictive Biomarker (PRD): KDM1A mRNA
Genes: KDM1A; AOF2; KDM1; KIAA0601; LSD1
Study NCT04622787 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT06779773 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05970250 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05074953 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06780696 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06781242 — Predictive Biomarker (PRD): ATP8B1 mRNA
Genes: ATP8B1; ATPIC; FIC1; PFIC
Study NCT05485974 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05760261 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05954832 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04821986 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06781905 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06781905 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT06781281 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06781281 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06781281 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06781281 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06781281 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04149288 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study NCT04149288 — Predictive Biomarker (PRD): PON1 mRNA
Genes: PON1; PON